Generic Name

Ioflupane I-123

Brand Names
Ioflupane, DaTscan
FDA approval date: March 01, 2011
Classification: Radioactive Diagnostic Agent
Form: Injection

What is Ioflupane (Ioflupane I-123)?

DaTscan is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian syndromes . In these patients, DaTscan may be used to help differentiate essential tremor from tremor due to PS . DaTscan is an adjunct to other diagnostic evaluations. DaTscan is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian syndromes . In these patients, DaTscan may be used to help differentiate essential tremor from tremor due to PS . DaTscan is an adjunct to other diagnostic evaluations.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

Summary: Background and Rationale Essential tremor (ET) affects over 6 million Americans and approximately 5% of adults over age 60. Patients with ET have a 10-20 times higher risk of developing Parkinson's disease (PD) compared to age-matched populations, with approximately 1% converting to PD annually. Post-mortem studies reveal Lewy body pathology in some ET patients, suggesting a subset may have prodro...

Video-oculography and Parkinson's Disease: A Prospective Study

Summary: This study aims to study, in patient with Parkinson's disease, mild to moderate stage (according to Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease, Postuma et al., 2015): * the evolution of oculomotricity markers over time. * the correlation between neurological evaluations (motor and non-motor scores), neuropsychological evaluations (cognitive disorders) and oculom...

The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

Summary: The purpose of this study is to identify and distinguish two different types of Progressive Apraxia of Speech through clinical imaging and testing.

Brand Information